Showing results (31-40 of 102) with videos related to
Sort By:
Pageof 11
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 22, 2014
[Comparative efficacy and safety of antidepressant mono- and multimodal therapy in elderly patients with depression (a clinical experience in a psychogeriatric hospital)]Ia B Kalyn, T P Safarova, V C Sheshenin, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 23, 2018
[Methods of augmentation of antidepressant therapy (on the model of complex therapy with the inclusion of actovegin) in gerontopsychiatric hospital]T P Safarova, O B Yakovleva, V S Sheshenin, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 22, 2007
[Prognosis of the syndrome of mild cognitive impairment: the data of the biennial follow-up study]S I Gavrilova, Ia B Fedorova, I F Roshchina, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 23, 2006
[Experience in clinical use of tanakan in the treatment of the syndrome of mild cognitive impairment]S I Gavrilova, Ia B Fedorova, I F Roshchina, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2009
[Galantamine (reminyl) in the treatment of severe Alzheimer's disease]S I Gavrilova, I V Kolykhanov, Ia B Kalyn, et al.Neuroscience and Behavioral Physiology|January 17, 2008
Prognosis of mild cognitive impairment syndrome: data from a two-year clinical follow-up studyS I Gavrilova, Ya B Fedorova, I F Roshchina, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 2, 2024
[Efficacy and safety of choline alfoscerate in the preventive therapy of dementia in elderly patients with Mild Cognitive Impairment: a three-year prospective comparative study]E V Ponomareva, L V Androsova, S A Krinsky, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 6, 2021
[Citicoline in the treatment of cognitive impairment in first-degree relatives of AD patients: the influence of the ApoE genotype]N D Selezneva, S I Gavrilova, I F Roshchina, et al.Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1991
[Specificity of neuropsychological syndromes in disorders of higher mental functions in Alzheimer's disease and senile dementia]N K Korsakova, N R Dybovskaia, I F Roshchina, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 17, 2011
[Cholinergic therapy of Alzheimer's disease and its effect on health and quality of life of caregivers to the patients]I V Kolykhalov, G A Rassadina, S I Gavrilova, et al.Pageof 11